These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 20012988)

  • 1. Morphological and immunophenotypic features of primary and metastatic giant cell tumour of bone.
    Alberghini M; Kliskey K; Krenacs T; Picci P; Kindblom L; Forsyth R; Athanasou NA
    Virchows Arch; 2010 Jan; 456(1):97-103. PubMed ID: 20012988
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The immunophenotype of osteoclasts and macrophage polykaryons.
    Maggiani F; Forsyth R; Hogendoorn PC; Krenacs T; Athanasou NA
    J Clin Pathol; 2011 Aug; 64(8):701-5. PubMed ID: 21561891
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bisphosphonate treatment of aggressive primary, recurrent and metastatic Giant Cell Tumour of Bone.
    Balke M; Campanacci L; Gebert C; Picci P; Gibbons M; Taylor R; Hogendoorn P; Kroep J; Wass J; Athanasou N
    BMC Cancer; 2010 Aug; 10():462. PubMed ID: 20799989
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CD33+ CD14- phenotype is characteristic of multinuclear osteoclast-like cells in giant cell tumor of bone.
    Forsyth RG; De Boeck G; Baelde JJ; Taminiau AH; Uyttendaele D; Roels H; Praet MM; Hogendoorn PC
    J Bone Miner Res; 2009 Jan; 24(1):70-7. PubMed ID: 18767926
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Drivers underpinning the malignant transformation of giant cell tumour of bone.
    Fittall MW; Lyskjaer I; Ellery P; Lombard P; Ijaz J; Strobl AC; Oukrif D; Tarabichi M; Sill M; Koelsche C; Mechtersheimer G; Demeulemeester J; Tirabosco R; Amary F; Campbell PJ; Pfister SM; Jones DT; Pillay N; Van Loo P; Behjati S; Flanagan AM
    J Pathol; 2020 Dec; 252(4):433-440. PubMed ID: 32866294
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phenotypic characterisation of mononuclear and multinucleated cells of giant cell tumour of bone.
    Joyner CJ; Quinn JM; Triffitt JT; Owen ME; Athanasou NA
    Bone Miner; 1992 Jan; 16(1):37-48. PubMed ID: 1531620
    [TBL] [Abstract][Full Text] [Related]  

  • 7. H3F3A G34 mutation DNA sequencing and G34W immunohistochemistry analysis in 366 cases of giant cell tumors of bone and other bone tumors.
    Gong L; Bui MM; Zhang W; Sun X; Zhang M; Yi D
    Histol Histopathol; 2021 Jan; 36(1):61-68. PubMed ID: 33021329
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic impact of reduced connexin43 expression and gap junction coupling of neoplastic stromal cells in giant cell tumor of bone.
    Balla P; Maros ME; Barna G; Antal I; Papp G; Sapi Z; Athanasou NA; Benassi MS; Picci P; Krenacs T
    PLoS One; 2015; 10(5):e0125316. PubMed ID: 25933380
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In Vitro Study of the Effects of Denosumab on Giant Cell Tumor of Bone: Comparison with Zoledronic Acid.
    Shibuya I; Takami M; Miyamoto A; Karakawa A; Dezawa A; Nakamura S; Kamijo R
    Pathol Oncol Res; 2019 Jan; 25(1):409-419. PubMed ID: 29159783
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Phenotypic and molecular differences between giant-cell tumour of soft tissue and its bone counterpart.
    Mancini I; Righi A; Gambarotti M; Picci P; Dei Tos AP; Billings SD; Simi L; Franchi A
    Histopathology; 2017 Sep; 71(3):453-460. PubMed ID: 28477388
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Giant cell tumours of bone treated with denosumab: histological, immunohistochemical and H3F3A mutation analyses.
    Kato I; Furuya M; Matsuo K; Kawabata Y; Tanaka R; Ohashi K
    Histopathology; 2018 May; 72(6):914-922. PubMed ID: 29206281
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biological characteristics of a novel giant cell tumor cell line derived from spine.
    Zhou Z; Li Y; Xu L; Wang X; Chen S; Yang C; Xiao J
    Tumour Biol; 2016 Jul; 37(7):9681-9. PubMed ID: 26801673
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunohistochemical expression of H3.3 G34W in 100 giant cell tumors of bone and its diagnostic mimics, including its value in resolving uncommon diagnostic scenarios: A single institutional study at a tertiary cancer referral center, India.
    Rekhi B; Dave V; Butle A; Dharavath B; Khetale S; Redhu AK; Singh R; Dutt A
    Indian J Pathol Microbiol; 2024 Jul; 67(3):542-552. PubMed ID: 38391356
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Histone H3.3 mutation in giant cell tumor of bone: an update in pathology.
    Yamamoto H; Ishihara S; Toda Y; Oda Y
    Med Mol Morphol; 2020 Mar; 53(1):1-6. PubMed ID: 31748824
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epidermal growth factor receptor signalling contributes to osteoblastic stromal cell proliferation, osteoclastogenesis and disease progression in giant cell tumour of bone.
    Balla P; Moskovszky L; Sapi Z; Forsyth R; Knowles H; Athanasou NA; Szendroi M; Kopper L; Rajnai H; Pinter F; Petak I; Benassi MS; Picci P; Conti A; Krenacs T
    Histopathology; 2011 Sep; 59(3):376-89. PubMed ID: 22034878
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunohistochemical analyses of beta-catenin and cyclin D1 expression in giant cell tumor of bone (GCTB): a possible role of Wnt pathway in GCTB tumorigenesis.
    Matsubayashi S; Nakashima M; Kumagai K; Egashira M; Naruke Y; Kondo H; Hayashi T; Shindo H
    Pathol Res Pract; 2009; 205(9):626-33. PubMed ID: 19324500
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association of HLA-DRB1 alleles with giant cell tumour of bone.
    Varanasi SS; Athanasou NA; Briceno I; Papiha SS; Datta HK
    J Clin Pathol; 1999 Oct; 52(10):782-4. PubMed ID: 10674041
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Histone 3.3 mutations in giant cell tumor and giant cell-rich sarcomas of bone.
    Righi A; Mancini I; Gambarotti M; Picci P; Gamberi G; Marraccini C; Dei Tos AP; Simi L; Pinzani P; Franchi A
    Hum Pathol; 2017 Oct; 68():128-135. PubMed ID: 28899740
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunophenotypic distinction between pigmented villonodular synovitis and haemosiderotic synovitis.
    Mahendra G; Kliskey K; Athanasou NA
    J Clin Pathol; 2010 Jan; 63(1):75-8. PubMed ID: 20026702
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diagnostic utility of histone H3.3 G34W, G34R, and G34V mutant-specific antibodies for giant cell tumors of bone.
    Yamamoto H; Iwasaki T; Yamada Y; Matsumoto Y; Otsuka H; Yoshimoto M; Kohashi K; Taguchi K; Yokoyama R; Nakashima Y; Oda Y
    Hum Pathol; 2018 Mar; 73():41-50. PubMed ID: 29241742
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.